Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urogenital Neoplasms × prednylidene × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Burkitt Lymphoma 12 Prostatic Neoplasms 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Large B-Cell, Diffuse 4 Plasmablastic Lymphoma 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Follicular 2 Immunoblastic Lymphadenopathy 2 Enteropathy-Associated T-Cell Lymphoma 2 Neuroblastoma 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Primary Effusion 1 Lymphoma, B-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Hormone-Resistant Prostate Cancer 1 Hodgkin Disease 1 Hematologic Neoplasms 1 HIV Infections 1 Composite Lymphoma 1 Blast Crisis 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Sunitinib 2 Paclitaxel 2 valrubicin 1 temsirolimus 1 sipuleucel-T 1 luprolide acetate gel depot 1 ferumoxtran-10 1 abiraterone 1 abemaciclib 1 Suspensions 1 Surveys and Questionnaires 1 Standard of Care 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Powders 1 Pemetrexed 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1 Educational Status 1 Docetaxel 1 Bevacizumab 1 Administration, Intravesical 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡